FDA Approves New Product to Treat Von Willebrand Disease Alphanate |

« FDA Approvals - FDA fees rise in latest budget (The Star-Ledger) WASHINGTON -- | Main | FDA Commissioner Announces Important Personnel Changes U.S. Food and Drug »

FDA Approves New Product to Treat Von Willebrand Disease Alphanate

FDA Approves New Product to Treat Von Willebrand Disease
Alphanate is the first biologic product approved for treatment of surgical and invasive procedures in patients with vWD. Alphanate is already approved for the prevention and control of bleeding in patients with Factor VIII deficiency due to hemophilia A or acquired Factor VIII deficiency

Additional information in: FDA Recalls